Framingham Risk Score for Cardiovascular Disease: Application to
Jordanian Community; A cross sectional study
Abstract
Objective: The aim of this study is to assess the protective measures
taken by the Jordanian population in order to decrease the risk of the
first cardiovascular event using Framingham score risk classification to
assess cardiac event risk. Methods: Several nationally representative
models of adult Jordanians were recruited in this study. Demographic
data and anthropometric parameters were documented. Framingham risk
score was calculated. Accordingly, cardiac event risk has been
determined. Google form was created to generate a survey. Social media
was utilized to extend the survey. Key findings: As expected, taking
lipid lowering medications has decreased the Framingham score
significantly, patients with high HDL value have lower Framingham score.
Significant difference in Framingham score between diploma and patients
with high school or less education level p-value 0.043. There was a
significant difference in Framingham score between nonsmokers and
sometimes smokers. The study revealed that 90% of the participants were
having low risk for developing CVD, 5% were at intermediate risk and
5% were at high risk for developing CVD. This was expected as the
average age was between 20-30 years. Conclusion: This study presented no
advantage and even some harm because of consuming daily low-dose aspirin
in some groups of people formerly thought to benefit from such
treatment. This new piece of information applies to patients who do not
have identified cardiovascular disease. If you have not had one of the
above situations or events and are older than 70 years, younger than 40
years, or at higher danger of bleeding because of a medical condition or
treatments, you should not consume aspirin for principal prevention of
heart disease. If you are between 40 and 70 years old, at decreased risk
of bleeding, and thought to be at increased risk of heart disease, you
might get advantage from using aspirin.